Literature DB >> 7652192

In vivo central actions of rat amylin.

S M Bouali1, S J Wimalawansa, F B Jolicoeur.   

Abstract

The purpose of the present study was to examine and compare the profile of neurobehavioral effects of rat amylin (r-amylin) and rat calcitonin gene-related peptide (rCGRP), two peptides having a 50% structural homology. The effects of synthetic r-amylin and rCGRP administered in several doses (0.312-80.0 micrograms) into the lateral cerebro-ventricle of rats on spontaneous activity, muscular tone, body temperature, nociception, food intake as well as their potential for inducing catalepsy, were investigated. Intraventricular administration of r-amylin or rCGRP significantly reduced spontaneous motor activity and markedly increased body temperature of animals in a dose-dependent related fashion. rCGRP produced a significant increase in muscular tone and induced cataleptic effect in animals, but r-amylin had no effect on these variables. Furthermore, neither r-amylin nor rCGRP were able to induce any significant effect on nociceptive response time of animals in the tail immersion test even with doses as large as 80.0 micrograms. Finally, the two peptides did not affect ad libitum food intake, but significantly reduced food consumption in 22 h food-deprived animals. Together, the results of the present study suggest that amylin may be involved in a diversity of neurophysiological processes but displays a different profile of neurobehavioral effects to that of CGRP which may involve different receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7652192     DOI: 10.1016/0167-0115(95)00009-z

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  7 in total

1.  Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys.

Authors:  Nicholas T Bello; Matthew H Kemm; Timothy H Moran
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-14       Impact factor: 3.619

2.  Amylin receptor signaling in the nucleus accumbens negatively modulates μ-opioid-driven feeding.

Authors:  Sarah K Baisley; Brian A Baldo
Journal:  Neuropsychopharmacology       Date:  2014-06-24       Impact factor: 7.853

3.  Central amylin acts as an adiposity signal to control body weight and energy expenditure.

Authors:  Peter Y Wielinga; Christian Löwenstein; Sabine Muff; Manuela Munz; Stephen C Woods; Thomas A Lutz
Journal:  Physiol Behav       Date:  2010-04-21

4.  Amylin suppresses acetic acid-induced visceral pain and spinal c-fos expression in the mouse.

Authors:  X Huang; J Yang; J K Chang; N J Dun
Journal:  Neuroscience       Date:  2009-12-01       Impact factor: 3.590

5.  Amylin acts in the central nervous system to increase sympathetic nerve activity.

Authors:  Caroline Fernandes-Santos; Zhongming Zhang; Donald A Morgan; Deng-Fu Guo; Andrew F Russo; Kamal Rahmouni
Journal:  Endocrinology       Date:  2013-05-03       Impact factor: 4.736

Review 6.  Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases.

Authors:  Nina Sonne; Morten A Karsdal; Kim Henriksen
Journal:  Mol Metab       Date:  2020-11-07       Impact factor: 7.422

Review 7.  Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.

Authors:  Tayla A Rees; Erica R Hendrikse; Debbie L Hay; Christopher S Walker
Journal:  Br J Pharmacol       Date:  2021-07-27       Impact factor: 9.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.